Publicaciones en colaboración con investigadores/as de Clínica Universitaria de Navarra (73)

2016

  1. Consequences of Delayed Diagnosis

    Cañadell's Pediatric Bone Sarcomas (Springer), pp. 139-146

2015

  1. A genome-wide scan identifies variants in NFIB associated with metastasis in patients with osteosarcoma

    Cancer Discovery, Vol. 5, Núm. 9, pp. 920-931

  2. Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer types

    Journal of the National Cancer Institute, Vol. 107, Núm. 12

  3. Germline TP53 Variants and Susceptibility to Osteosarcoma

    Journal of the National Cancer Institute, Vol. 107, Núm. 7

  4. Lipid nanoparticles enhance the efficacy of chemotherapy in primary and metastatic human osteosarcoma cells

    Journal of Drug Delivery Science and Technology, Vol. 30, pp. 435-442

2014

  1. Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33

    Human Molecular Genetics, Vol. 23, Núm. 24, pp. 6616-6633

2013

  1. El niño ante la muerte

    Revista Espanola de Pediatria, Vol. 69, Núm. 5, pp. 238-247

  2. Genome-wide association study identifies two susceptibility loci for osteosarcoma

    Nature Genetics, Vol. 45, Núm. 7, pp. 799-803

2012

  1. Cortactin (CTTN) overexpression in osteosarcoma correlates with advanced stage and reduced survival

    Cancer Biomarkers, Vol. 10, Núm. 1, pp. 35-41

  2. Unexpected diagnosis in the case of a 16-year-old boy with back pain

    Medicina Clinica, Vol. 139, Núm. 6

2009

  1. Methotrexate in Pediatric Osteosarcoma: Response and Toxicity in Relation to Genetic Polymorphisms and Dihydrofolate Reductase and Reduced Folate Carrier 1 Expression

    Journal of Pediatrics, Vol. 154, Núm. 5, pp. 688-693

  2. Profiling of chemonaive osteosarcoma and paired-normal cells identifies EBF2 as a mediator of osteoprotegerin inhibition to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis

    Clinical Cancer Research, Vol. 15, Núm. 16, pp. 5082-5091

  3. Prognostic factors and outcomes for osteosarcoma: An international collaboration

    European Journal of Cancer, Vol. 45, Núm. 13, pp. 2367-2375

  4. Proteomic analysis of chemonaïve pediatric osteosarcomas and corresponding normal bone reveals multiple altered molecular targets

    Journal of Proteome Research, Vol. 8, Núm. 8, pp. 3882-3888

2008

  1. CDH11 expression is associated with survival in patients with osteosarcoma

    Cancer Genomics and Proteomics, Vol. 5, Núm. 1, pp. 37-42

2006

  1. Papel de la radioterapia en los tumores malignos de la infancia

    Revisiones en Cancer, Vol. 20, Núm. 5, pp. 229-246

  2. Síndrome de Papillon-Lefèvre: Caso clínico y revisión bibliográfica

    Acta Pediatrica Espanola, Vol. 64, Núm. 10, pp. 514-517

2004

  1. Current Role for Resection of Thoracic Metastases in Children and Young Adults - Do we Need Different Strategies for this Population?

    Thoracic and Cardiovascular Surgeon, Vol. 52, Núm. 2, pp. 90-95

  2. Feasibility report of conservative surgery, perioperative high-dose-rate brachytherapy (PHDRB), and low-to-moderate dose external beam radiation therapy (EBRT) in pediatric sarcomas

    Brachytherapy, Vol. 3, Núm. 4, pp. 196-200

  3. Imatinib Inhibits Proliferation of Ewing Tumor Cells Mediated by the Stem Cell Factor/KIT Receptor Pathway, and Sensitizes Cells to Vincristine and Doxorubicin-Induced Apoptosis

    Clinical Cancer Research, Vol. 10, Núm. 2, pp. 751-761